Abstract
The endogenous neuropeptide galanin is ubiquitously expressed throughout the mammalian brain. Through the galanin receptors GalR1-3, galanin has been demonstrated to modulate both glutamatergic and GABAergic neurotransmission, and this appears to be important in epilepsy and seizure activity. Accordingly, galanin analogues are likely to provide a new approach to seizure management. However, since peptides are generally poor candidates for therapeutic agents due to their poor metabolic stability and low brain bioavailability, a search for alternative strategies for the development of galanin-based anti-convulsant drugs was prompted. Based on this, a rationally designed GalR1 preferring galanin analogue, NAX-5055, was synthesized. This compound demonstrates anti-convulsant actions in several animal models of epilepsy. However, the alterations at the cellular level leading to this anti-convulsant action of NAX-5055 are not known. Here we investigate the action of NAX-5055 at the cellular level by determining its effects on excitatory and inhibitory neurotransmission, i.e. vesicular release of glutamate and GABA, respectively, in cerebellar, neocortical and hippocampal preparations. In addition, its effects on cell viability and ne...Continue Reading
References
Apr 1, 1991·Journal of Neuroscience Methods·L StoppiniD Muller
Jun 20, 1989·European Journal of Pharmacology·Y B Ari, M Lazdunski
Aug 1, 1989·Neurochemical Research·J Drejer, A Schousboe
Jan 1, 1985·Developmental Neuroscience·A SchousboeE Meier
Dec 16, 1983·Journal of Immunological Methods·T Mosmann
Jan 1, 1983·Journal of Neuroscience Research·O M LarssonA Schousboe
May 19, 1980·Brain Research·S R SnodgrassM Dichter
Apr 30, 1993·Neuroscience Letters·S ZiniY Ben-Ari
Jun 1, 1993·Neuroscience·B BelhageA Schousboe
Jan 1, 1995·Journal of Molecular Neuroscience : MN·M C BurgevinE Habert-Ortoli
Sep 22, 1998·Nature Biotechnology·M PoogaU Langel
Oct 28, 1998·Proceedings of the National Academy of Sciences of the United States of America·H CremerP M Lledo
Oct 13, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·D Attwell, S B Laughlin
Nov 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·M KokaiaT Hökfelt
Feb 5, 2002·Annual Review of Physiology·Robert S Zucker, Wade G Regehr
Sep 11, 2003·Journal of Neurophysiology·George B Richerson, Yuanming Wu
Dec 18, 2003·The Journal of Physiology·J Josh LawrenceChris J McBain
Oct 26, 2005·Neuropharmacology·Craig D McCollJohn M Bekkers
Nov 2, 2005·Nature Reviews. Neuroscience·Roger A Nicoll, Dietmar Schmitz
Nov 9, 2007·Neuroscience·I Kanter-SchlifkeM Kokaia
May 27, 2008·Cellular and Molecular Life Sciences : CMLS·K MitsukawaT Bartfai
Dec 5, 2008·Journal of Medicinal Chemistry·Grzegorz BulajH Steve White
Apr 1, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·H Steve WhiteGrzegorz Bulaj
Mar 15, 2011·Neurotoxicology·Anitha B AlexKaren S Wilcox
Aug 24, 2013·Frontiers in Endocrinology·Arne SchousboeHelle S Waagepetersen
Mar 15, 2014·Neurochemical Research·Arne SchousboeH Steve White
Citations
Apr 12, 2017·Journal of Neuroscience Research·Blanca I AldanaAnne B Walls
Jan 19, 2017·Reviews in the Neurosciences·Mojdeh NavidhamidiNasrin Mehranfard
Aug 21, 2020·Journal of Neurophysiology·James Weifu Lee
Nov 19, 2020·International Journal of Molecular Sciences·Cecilia Zavala-TecuapetlaHiram Luna-Munguia
Aug 11, 2018·ACS Chemical Neuroscience·Piotr PodlaszKrzysztof Wasowicz